1. Home
  2. SID vs NVAX Comparison

SID vs NVAX Comparison

Compare SID & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia Siderurgica Nacional S.A.

SID

Companhia Siderurgica Nacional S.A.

HOLD

Current Price

$1.28

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.03

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SID
NVAX
Founded
1941
1987
Country
Brazil
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
SID
NVAX
Price
$1.28
$8.03
Analyst Decision
Strong Sell
Hold
Analyst Count
1
9
Target Price
$1.40
$11.33
AVG Volume (30 Days)
7.6M
3.7M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$2.38
N/A
Revenue Next Year
$2.49
N/A
P/E Ratio
N/A
$3.16
Revenue Growth
N/A
64.69
52 Week Low
$1.11
$5.01
52 Week High
$2.20
$11.85

Technical Indicators

Market Signals
Indicator
SID
NVAX
Relative Strength Index (RSI) 43.68 34.64
Support Level N/A $8.01
Resistance Level $1.64 $8.45
Average True Range (ATR) 0.06 0.55
MACD 0.02 -0.28
Stochastic Oscillator 84.21 9.93

Price Performance

Historical Comparison
SID
NVAX

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: